Medifast

Medifast Debt/EBITDA

The Total Debt to EBITDA Ratio of Medifast (MED) as of Nov 20, 2026 is -1.18. In the previous year, Total Debt to EBITDA Ratio was 5.60 — a change of -121.08% (lower).

Debt/EBITDA

-1.18

YoY

-121.08%

Last updated:

Total Debt to EBITDA Ratio of Medifast is 2025 -1.18 . Total Debt to EBITDA Ratio of Medifast was 2024 5.60 . It decreases by -121.08% lower compared to the previous year.

The Medifast Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.15 USD
Jan 1, 2020
0.08 USD
Jan 1, 2021
0.15 USD
Jan 1, 2022
0.14 USD
Jan 1, 2023
0.17 USD
Jan 1, 2024
5.60 USD
Jan 1, 2025
-1.18 USD
The Medifast Debt/EBITDA history
YEARDebt/EBITDAYoY
-1.18-121.08%
5.60+3,117.39%
0.17+23.54%
0.14-6.33%
0.15+80.90%
0.08-44.31%
0.15—
0.00—
0.00-100.00%
0.03+279.88%
0.01-51.28%
0.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medifast Stock analysis

What does Medifast do? Medifast Inc. is a leading provider of health and wellness solutions, with its headquarters in Baltimore, Maryland. The company was founded in 1980 by Dr. William Vitale and has since experienced continuous growth. Medifast's nutrition and health products are available in the United States, Canada, and Puerto Rico. Medifast is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medifast stock

Total Debt to EBITDA Ratio of Medifast is -1.18 in 2025.

Total Debt to EBITDA Ratio of Medifast changed from 5.60 to -1.18, representing a -121.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Medifast since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Medifast with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Medifast

All Key Metrics — Medifast